EI1 (Cat.No:I001607) is a chemical compound with potential therapeutic applications. It acts as a selective inhibitor of enhancer of zeste homolog 2 (EZH2), an enzyme involved in epigenetic regulation. By inhibiting EZH2, EI1 shows potential in cancer treatment, particularly in inhibiting tumor growth and metastasis. Further research is ongoing to explore its efficacy and safety profiles.
Catalog Number | I001607 |
CAS Number | 1418308-27-6 |
Synonyms | 6-cyano-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-1-pentan-3-ylindole-4-carboxamide |
Molecular Formula | C23H26N4O2 |
Purity | 95% |
Target | EZH2 |
Solubility | 10 mM in DMSO |
Storage | Store at -20℃ |
IC50 | 15±2 nM (EZH2 wild type); 13±3 nM (EZH2 Y641F mutant type) [1] |
IUPAC Name | 6-cyano-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-1-pentan-3-ylindole-4-carboxamide |
InChI | InChI=1S/C23H26N4O2/c1-5-17(6-2)27-8-7-18-19(10-16(12-24)11-21(18)27)22(28)25-13-20-14(3)9-15(4)26-23(20)29/h7-11,17H,5-6,13H2,1-4H3,(H,25,28)(H,26,29) |
InChIKey | PFHDWRIVDDIFRP-UHFFFAOYSA-N |
SMILES | CCC(CC)N1C=CC2=C(C=C(C=C21)C#N)C(=O)NCC3=C(C=C(NC3=O)C)C |
Reference | <p style=/line-height:25px/> </p> |